Fri, Nov 21, 2014, 7:18 AM EST - U.S. Markets open in 2 hrs 12 mins

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • terry_insm terry_insm Feb 8, 2014 10:05 AM Flag

    " there have never been results that lived up to expectations here"

    Even the Arikace for CF was not compelling. I think what kolob was opining was Institutions believe a Phase 3 will not be necessary. My original opinion was that the results would "need some additional work"....

    IF Insmed announces "Arikace for NTM results positive( not encouraging ) and the company will start a Phase3 thereby delaying by 3+ years NTM, ...therein is the risk and stock slaughter. News from the FDA is more often leaked than a company just announcing results and then going to the FDA. In Insmeds case they are taking the results to the FDA seeking a "regulatory pathway" (what is necessary to file- if anything).

    I agree results have always disappointed with Insmed, NTM is the watershed event for success or failure. If you have profits,you can always trade back in. Novices opine "You will miss the move"! - yup and that move may be a horrific one down. Lets hope NTM is Insmeds truly first real success Good Luck

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
13.24+0.40(+3.12%)Nov 20 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Splunk, Inc.
NasdaqGSThu, Nov 20, 2014 4:00 PM EST
Foot Locker, Inc.
NYSEThu, Nov 20, 2014 4:02 PM EST
GameStop Corp.
NYSEThu, Nov 20, 2014 4:00 PM EST